The Italian Competition Authority opens an Article 102 TFEU investigation against a producer of generic drugs (Incremento Prezzo Farmaco-Aspen)

In the case Incremento Prezzo Farmaco-Aspen (Aspen) the Italian Competition Authority (ICA) has recently opened an Article 102 TFEU investigation against Aspen, a South African manufacturer of generic drugs [1]. Aspen was alleged to have abused its dominance position by imposing excessive prices on the Italian national health system for the supply of a number of anti-cancer drugs. The decision of the Italian Competition Authority The ICA started the proceedings on the basis of the results of an enquiry

L'accès à cet article est réservé aux abonnés

Déjà abonné ? Identifiez-vous

L’accès à cet article est réservé aux abonnés.

Lire gratuitement un article

Vous pouvez lire cet article gratuitement en vous inscrivant.

 

Version PDF

Auteur

  • Desogus Law Office (Cagliari)

Citation

Michele Giannino, The Italian Competition Authority opens an Article 102 TFEU investigation against a producer of generic drugs (Incremento Prezzo Farmaco-Aspen), 19 novembre 2014, e-Competitions November 2014, Art. N° 70817

Visites 273

Tous les numéros

  • Latest News issue 
  • Tous les News issues
  • Latest Special issue 
  • Tous les Special issues